(Information sent by the signatory company)
Leading CDMO adopts Veeva Vault QMS, Vault QualityDocs and Vault Training to standardize quality processes and manage GxP content across their organization.
BARCELONA, Spain, Dec. 19, 2023/PRNewswire/ — Veeva Systems (NYSE: VEEV) today announced that Recipharm, a global contract development and manufacturing organization (CDMO), will use Veeva Vault QMS, Veeva Vault QualityDocs and Veeva Vault Training to optimize your quality operations. Veeva quality applications will help Recipharm achieve greater quality oversight, use resources more effectively, accelerate validation, and maintain readiness for inspections.
“Harmonizing quality processes and GxP documentation across all Recipharm sites will make our quality operations more efficient and scalable,” explained Vanessa Nardolillo, Head of Quality Management and Regulatory Affairs at Recipharm. “With Veeva Vault Quality, Recipharm is setting a new global standard for quality management, site collaboration and compliance. The system will allow us to offer our customers a standard approach to quality. It forms a key part of our approach in continuous improvement to unleash quality excellence in all our services.
Recipharm offers manufacturing services to pharmaceutical and medical device companies. Vault QMS will help Recipharm gain greater control and visibility of quality processes, with Vault QualityDocs, driving efficient GxP content management and information sharing between sites. With Vault Training, Recipharm can put learning content and curricula into practice to help ensure GxP effectiveness and compliance.
“Unifying quality processes, content and training in Veeva Vault Quality will help Recipharm maintain contract development and manufacturing as it continues to scale,” said Rob Gaertner, vice president of quality strategy for Europe at Veeva. “We are excited to partner with Recipharm as they evolve their quality operations.”
About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence and customer success, Veeva serves more than 1,000 customers, from the world’s largest biopharmaceutical companies to emerging biotechnology companies. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com/eu.
Veeva Forward-Looking Statements
This release contains forward-looking statements about Veeva’s products and services and the expected results or benefits from the use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we undertake no obligation to update such statements. There are numerous risks that have the potential to adversely affect our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended October 31, 2023, which can be found here (a summary of the risks that may affect our business can be found on pages 38 and 39) and in our subsequent filings with the SEC, which can be accessed at sec.gov.
Contact:
Jeremy WhittakerVeeva Systems 49-695-095-5486jeremy.whittaker@veeva.com
Logo – https://mma.prnewswire.com/media/1488285/4462725/Veeva_Systems_Logo.jpg
View original content: https://www.prnewswire.com/news-releases/recipharm-armoniza-sus-operaciones-de-calidad-global-con-veeva-vault-quality-302019220.html
